Drug profile · INN
dezocine
DALGAN
dezocine (DALGAN) is a kappa opioid receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — dezocine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
dezocine (DALGAN) is a kappa opioid receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Kappa opioid receptor antagonist
Primary target: Kappa-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dezocine?
dezocine (DALGAN) is a kappa opioid receptor antagonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dezocine?
DALGAN is a marketed brand name for dezocine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dezocine?
dezocine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.